According to recent filings covering the 90 days ending December 12, 2025, the three most significant insider holders at Madrigal Pharmaceuticals are Director Rebecca Taub (461.04K shares), Director Paul A Friedman (187.16K shares), President And CEO William John Sibold (150.07K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Bros. Advisors Lp Baker | 1,859,091 | 20 Aug, 2025 | |
| Rebecca Taub | 455,589 | 12 Dec, 2025 | |
| Fred B Craves | 361,076 | 14 Mar, 2025 | |
| Paul A Friedman | 187,164 | 12 Dec, 2025 | |
| William John Sibold | President And CEO | 150,074 | 04 Dec, 2025 |
| Richard S Levy | 21,197 | 14 Nov, 2025 | |
| Alex G. Howarth | Chief Financial Officer | 18,737 | 25 Jan, 2024 |
| Brian Joseph Lynch | SVP And General Counsel | 17,691 | 25 Jan, 2024 |
| Remy Sukhija | Chief Commercial Officer | 15,001 | 18 Jan, 2023 |
| Mardi Dier | EVP And Cfo | 10,440 | 03 Dec, 2025 |
| Carole Huntsman | Chief Commercial Officer | 10,032 | 21 Nov, 2025 |
| Shannon T Kelley | General Counsel | 9,173 | 18 Aug, 2025 |
| David Soergel | Chief Medical Officer | 7,545 | 16 May, 2025 |
| Robert E. Waltermire | Senior VP And Chief Pharma Dev. | 5,789 | 07 Mar, 2025 |
| James M Daly | 2,627 | 24 Jun, 2025 | |
| Kenneth Bate | 2,627 | 07 Nov, 2025 | |
| City Capital Llc Bay | 1,261 | 07 Dec, 2021 | |
| Jacqualyn A Fouse | 1,097 | 24 Jun, 2025 | |
| Daniel J. Brennan | 967 | 05 Aug, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Dec, 2025 | Paul A Friedman | Common Stock | A | 24,800 | $15.80 | 211,964 | D | M |
| 10 Dec, 2025 | Rebecca Taub | Common Stock | A | 18,650 | $15.80 | 479,694 | D | M |
| 10 Dec, 2025 | Rebecca Taub | Common Stock | D | 491 | $547.76 | 479,203 | D | S |
| 10 Dec, 2025 | Paul A Friedman | Common Stock | D | 624 | $547.75 | 211,340 | D | S |
| 10 Dec, 2025 | Rebecca Taub | Common Stock | D | 369 | $548.56 | 478,834 | D | S |
| 10 Dec, 2025 | Paul A Friedman | Common Stock | D | 535 | $548.51 | 210,805 | D | S |
| 10 Dec, 2025 | Paul A Friedman | Common Stock | D | 409 | $549.99 | 210,396 | D | S |
| 10 Dec, 2025 | Rebecca Taub | Common Stock | D | 486 | $550.07 | 478,348 | D | S |
| 10 Dec, 2025 | Rebecca Taub | Common Stock | D | 4,723 | $550.99 | 473,625 | D | S |
| 10 Dec, 2025 | Paul A Friedman | Common Stock | D | 4,316 | $550.93 | 206,080 | D | S |
| 10 Dec, 2025 | Paul A Friedman | Common Stock | D | 7,193 | $551.67 | 198,887 | D | S |
| 10 Dec, 2025 | Rebecca Taub | Common Stock | D | 4,410 | $551.85 | 469,215 | D | S |
| 10 Dec, 2025 | Paul A Friedman | Common Stock | D | 5,533 | $552.74 | 193,354 | D | S |
| 10 Dec, 2025 | Rebecca Taub | Common Stock | D | 3,857 | $552.81 | 465,358 | D | S |
| 10 Dec, 2025 | Paul A Friedman | Common Stock | D | 5,001 | $553.83 | 188,353 | D | S |
| 10 Dec, 2025 | Rebecca Taub | Common Stock | D | 3,087 | $553.88 | 462,271 | D | S |
| 10 Dec, 2025 | Paul A Friedman | Common Stock | D | 1,029 | $555.00 | 187,324 | D | S |
| 10 Dec, 2025 | Rebecca Taub | Common Stock | D | 1,027 | $554.84 | 461,244 | D | S |
| 10 Dec, 2025 | Rebecca Taub | Common Stock | D | 200 | $555.39 | 461,044 | D | S |
| 10 Dec, 2025 | Paul A Friedman | Common Stock | D | 160 | $555.39 | 187,164 | D | S |